Evidence map›Paper›PMID 33736704›Full record

ArticleMicrobiome2021

Xylitol enhances synthesis of propionate in the colon via cross-feeding of gut microbiota.

Shasha Xiang, Kun Ye, Mian Li, Jian Ying, Huanhuan Wang, Jianzhong Han, Lihua Shi, Jie Xiao, Yubiao Shen, Xiao Feng and 9 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Microbiome, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Oral hygiene agents at work: effects onFrontiers in cellular and infection microbiology · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Shasha Xiang *School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Kun Ye *School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Mian LiZhejiang Huakang Pharmaceutical Co., Ltd., Kaihua, 324302, China.
Jian YingNutrition and Health Research Institute, COFCO Ltd., Beijing, 102209, China.
Huanhuan WangSchool of Medicine, Hangzhou Normal University, Hangzhou, 310018, China.
Jianzhong HanSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Lihua ShiZhejiang Huakang Pharmaceutical Co., Ltd., Kaihua, 324302, China.
Jie XiaoNutrition and Health Research Institute, COFCO Ltd., Beijing, 102209, China.
Yubiao ShenYangtze Delta Institute of Tsinghua University, Jiaxing, 314000, China.
Xiao FengSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Xuan BaoSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Yiqing ZhengSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Yin GeSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Yalin ZhangSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Chang LiuSchool of Food Science and Technology, Jiangnan University, Wuxi, 214122, China.
Jie ChenSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Yuewen ChenSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Shiyi TianSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Xuan ZhuSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China. zhuxuan@zjgsu.edu.cn.ORCID 0000-0003-2280-4707
Zhejiang Gongshang University · CNZhejiang Hisun Pharmaceutical (China) · CNHangzhou Normal University · CNJiangnan University · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXylitol, a white or transparent polyol or sugar alcohol, is digestible by colonic microorganisms and promotes the proliferation of beneficial bacteria and the production of short-chain fatty acids (SCFAs), but the mechanism underlying these effects remains unknown. We studied mice fed with 0%, 2% (2.17 g/kg/day), or 5% (5.42 g/kg/day) (weight/weight) xylitol in their chow for 3 months. In addition to the in vivo digestion experiments in mice, 3% (weight/volume) (0.27 g/kg/day for a human being) xylitol was added to a colon simulation system (CDMN) for 7 days. We performed 16S rRNA sequencing, beneficial metabolism biomarker quantification, metabolome, and metatranscriptome analyses to investigate the prebiotic mechanism of xylitol. The representative bacteria related to xylitol digestion were selected for single cultivation and co-culture of two and three bacteria to explore the microbial digestion and utilization of xylitol in media with glucose, xylitol, mixed carbon sources, or no-carbon sources. Besides, the mechanisms underlying the shift in the microbial composition and SCFAs were explored in molecular contexts.

resultsIn both in vivo and in vitro experiments, we found that xylitol did not significantly influence the structure of the gut microbiome. However, it increased all SCFAs, especially propionate in the lumen and butyrate in the mucosa, with a shift in its corresponding bacteria in vitro. Cross-feeding, a relationship in which one organism consumes metabolites excreted by the other, was observed among Lactobacillus reuteri, Bacteroides fragilis, and Escherichia coli in the utilization of xylitol. At the molecular level, we revealed that xylitol dehydrogenase (EC 1.1.1.14), xylulokinase (EC 2.7.1.17), and xylulose phosphate isomerase (EC 5.1.3.1) were key enzymes in xylitol metabolism and were present in Bacteroides and Lachnospiraceae. Therefore, they are considered keystone bacteria in xylitol digestion. Also, xylitol affected the metabolic pathway of propionate, significantly promoting the transcription of phosphate acetyltransferase (EC 2.3.1.8) in Bifidobacterium and increasing the production of propionate.

conclusionsOur results revealed that those key enzymes for xylitol digestion from different bacteria can together support the growth of micro-ecology, but they also enhanced the concentration of propionate, which lowered pH to restrict relative amounts of Escherichia and Staphylococcus. Based on the cross-feeding and competition among those bacteria, xylitol can dynamically balance proportions of the gut microbiome to promote enzymes related to xylitol metabolism and SCFAs. Video Abstract.

Indexed as

Gastrointestinal MicrobiomeAnimalsColonFatty Acids, VolatileMicePropionatesRNA, Ribosomal, 16SXylitolFatty Acids, VolatilePropionatesRNA, Ribosomal, 16SXylitolCross-feedingIntestinal microorganismIn vitro colonic simulation system (CDMN)Xylitol

Identifiers

PMID33736704
PMCPMC7977168
OpenAlexW3137864406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.